We tested the hypothesis that mutations in the human ventricular essential myosin light chain (hVLC-1) that are associated with hypertrophic cardiomyopathy (HCM) affect protein structure, binding to the IQ1 motif of cardiac myosin heavy chain (MYH) and sarcomeric sorting in neonatal cardiomyocytes.
Introduction
Familial hypertrophic cardiomyopathy (HCM) (FHC) is characterized by a hypertrophic left ventricle and interventricular septum, myofibrillar disarray, abnormal ECG, and sudden cardiac death. 1 FHC is an autosomal dominant disease originating from mutations in genes that encode for sarcomeric proteins, including the ventricular essential myosin light chain (ELC) of type II myosin. 2 Myosin II, the motor protein of muscle, is composed of two heavy chains (MYH, myosin heavy chain) and four non-covalently linked light chains (MLC, myosin light chain). 3, 4 The lever arm of the MYH contains two IQ motifs in tandem. IQ1 binds the ELC, whereas IQ2 binds the regulatory myosin light chain. 3 -9 In the heart, an atrial-specific (ALC-1) and a ventricular-specific (VLC-1) ELC isoform are expressed. 7, 10 Cardiac
ELCs consist of an actin-binding lysine-rich N-terminus, a proline-rich antenna-like spacer, and a C-terminal lever-arm-binding domain which contains four helix-loop -helix EF-hand domains. 11 The first mutations of the human VLC-1 gene (MYL3, accession NP_000249.1; hVLC-1), associated with a rare form of FHC, were M149V and R154H. 12 In addition, three more MYL3 mutations were reported, E143K, 13 E56G, 14 and A57G, 15 which associate with FHC. Structural comparison with the scallop ELC 6 locates the E56G and A57G mutations of hVLC-1 to the a-helix of the first EF hand and E143K, M149V, and R154H to the third EF-hand motif. 16 Moreover, the pathomechanisms of all five reported MYL3 mutations are still obscure. Two transgenic mouse models 17, 18 and one transgenic rabbit model 19 overexpressing VLC-1 with M149V have been generated.
The mouse model which overexpressed the mutated hVLC-1 18 recapitulated the cardiomyopathy. However, a recapitulation of the human cardiomyopathic phenotype could not be observed with the rabbit model which overexpressed the mutated rabbit VLC-1 19 and the mouse model which overexpressed mutated mouse VLC-1. 17 Most recently, a fourth transgenic mouse model overexpressing the A57G mutation of human ventricular ELC was generated, but did not recapitulate HCM. 20 The binding of the ELC to the IQ1 motif of the lever arm of MYH is required for the normal function of myosin. Studies with singlemyosin molecules lacking ELCs revealed only about one-third of the force generated by native myosin. 21 In fact, 'lazy susan', a mutant zebrafish with severely reduced cardiac functions, revealed a truncation in the myosin-binding C-terminus of the cardiac A1. 22 We therefore tested the hypothesis that disease-related MYL3 mutations could affect binding properties of hVLC-1 with the myosin lever arm. To this end, we produced seven recombinant fusion proteins: a rat b-myosin head-rod fragment aa664-915 (rb-MYH 664 -915 IQ2 ala4 ), a normal hVLC-1, and five different hVLC-1s with an M149V, E143K, A57G, E56G, or R154H mutation. Protein-protein interactions between hVLC-1 isoforms and MYH were analysed by surface plasmon resonance and fluorescence lifetime measurements.
To show that disturbed affinities of mutated hVLC-1 with MYH correlate with different sarcomeric sorting properties, we applied a double epitope-tagging competition method according to Soldati and Perriard 23 and Petzhold et al. 24 In our experiments described herein, we tagged two different light-chain isoforms with two different epitopes, i.e. HIS and myc. The cDNAs of both differently tagged lightchain forms were then co-transfected into neonatal cardiomyocytes for co-expression within the same cell. Expression and intracellular localization of both proteins are finally achieved using antibodies which specifically recognize the tags in the immunofluorescence analysis. With this method, we showed recently that the incorporation of cardiac ELC isoproteins into the sarcomere is variable. 24 In this paper, we show that all disease-related mutated hVLC-1s bind slightly but significantly weaker (with a two to three-fold higher K D ) to the myosin lever arm than does normal hVLC-1. In particular, the E56G mutation revealed a 30-fold higher K D . This may provide the molecular basis for its disturbed conformation in permeabilized muscle fibres and minor sarcomeric sorting specificity compared with normal hVLC-1.
Methods

Recombinant proteins
Cloning and generation of recombinant fusion proteins of human essential ventricular myosin light chain (hVLC-1) forms and a myosin head-rod fragment of amino acids (aa) 665 -915 with an N-terminal hexahistidine (HIS)-tag/40aa spacer and an N-terminal glutathione S-transferase (GST)-tag/14aa spacer, respectively, were performed as described recently. 25 The M149V, E143K, A57G, R154H, and E56G mutations were introduced into the hVLC-1 using the QuikChange site-directed mutagenesis kit (StratageneEurope, Amsterdam, the Netherlands). To avoid unspecific binding to the IQ2 domain and to provide a stretched rather than a sphere-like myosin head-rod structure, we deteriorated the IQ2 domain of rb-MYH 664 -915 by alanine-scanning site-directed mutagenesis (rb-MYH 664 -915 IQ2 ala4 ). 25 All constructs were checked by restriction site mapping and DNA sequencing.
Western blot analysis
After separation by 12% SDS -PAGE, recombinant proteins were transferred to a nitrocellulose membrane (90 min, 250 mA) and incubated over night with the primary anti-HIS-tag antibody (Qiagen, Hilden, Germany) or anti-GST-tag antibody (Invitrogen, Karlsruhe, Germany). A peroxidase-conjugated anti-mouse antibody (Biogenes, Berlin, Germany) was used as secondary antibody (1 h, room temperature).
Immunoreactive proteins were visualized via the Immobilon TM Western (Millipore, Billerica, MO, USA) and X-ray film (GE Healthcare, Uppsala, Sweden).
Construction of epitope-tagged hVLC-1 expression plasmids
hVLC-1 and E56G-mutated hVLC-1 (hVLC-1 E56G ) were cloned with an Nterminal HIS or myc tag, respectively, as previously reported. 24 To prepare eukaryotic plasmids expressing normal and mutated hVLC-1, the corresponding cDNA clones (ImaGenes, Berlin, Germany) were used as templates and amplified by PCR. To perform PCR, two pairs for hVLC-1
E56G
were used: sense primer: 5 ′ -CCaagcttGCCACCATGCATCATCATCA TCATCATATGGCCCCCAAAAAGCC-3 ′ ; antisense primer: 5 ′ -ACC aagcttTTAGCTGGACATGATGTGCTTCACAAA-3 ′ . Primers for hVLC-1 were the same as described recently: 24 sense primer:
The HIS and myc tags (bold letters) and the restriction site HindIII (italic letters) were incorporated into primers to facilitate subcloning into the eukaryotic expression vector pcDNA3.1(+) (Invitrogen). In each sense primer, following the HindIII site, a Kozak consensus sequence (GCCAC CATG) 26 for generating a ribosome-binding site and an ATG start site were added to initiate expression in eukaryotic cells. PCR products were cut with HindIII and ligated with HindIII-cut pcDNA3.1(+). These plasmids were then transfected into Top10 cells and purified using Invisorb Plasmid Maxi Kit (Invitek, Berlin, Germany).
Analysis of protein -protein interactions by surface plasmon resonance
Binding studies of the recombinant fusion proteins and data evaluation (BIAcore AB) were carried out in a BIAcore 2000 Instrument (Uppsala, Sweden) at 258C using the sensor chip CM5 (BIAcore AB) as recently described. 25 Equilibrium K D values were determined from the rate constants k on and k off according to
Circular dichroism spectroscopy and melting curves
Circular dichroism (CD) spectra of ELC fusion proteins were recorded in 1 mm quartz cuvettes (Hellma, Müllheim, Germany) on a J-720 spectrometer (Jasco, Tokyo, Japan) at 258C using a scanning speed of 50 nm/min, a bandwidth of 1 nm, and a response time of 2 s. Proteins were dissolved at concentrations of 3 or 6 mM in 10 mM Tris, 120 mM NaF, pH 7.4. Presented spectra give the mean residual molar ellipticity [Q] of one out of four independent experiments. Secondary structure compositions were estimated by decomposing CD spectra in the range of 200 -240 nm into reference spectra obtained from proteins of known structures. 27 Thermal denaturation curves were obtained by monitoring the CD signal at 218 nm while increasing the temperature from 4 to 948C at a ramp rate of 18C/min and a response time of 4 s.
Intracompartmental sorting in neonatal cardiomyocytes
Neonatal rat cardiomyocytes prepared from 1-3-day-old SpragueDawley rats were purchased commercially (ERDE, Berlin, Germany) and cultivated as described previously. 28 Intracompartmental sorting of hVLC-1 and hVLC-1 E56G in neonatal cardiomyocytes was performed as described recently. 24 A total of 10 × 10 4 neonatal rat cardiomyocytes were seeded into each well of a 12-well plate. After 18 h incubation, the medium was replaced with 1 mL of SM20-I (Biochrome, Berlin, Germany). 28 One microgram of plasmid DNA (in 100 mL of SM20-I)
was mixed with 4 mL of'Lipofectamine (in 100 mL of SM20-I) and incubated for 20 min at room temperature. The resultant complex mixture Effects of mutations of essential myosin light chains (overall 200 mL) was added to the cells seeded in a 12-well plate. The mixture was replaced with fresh medium 6 h after transfection, and after 18 h cells were washed twice with PBS. Cells were fixed with 3. 7% paraformaldehyde for 10 min, washed with PBS, and permeabilized with 0.5% Triton X-100 (in PBS) for 10 min, followed by another PBS wash. Subsequently, 0.2% fish skin gelatine was added for 30 min to block nonspecific-binding sites, followed by incubation at 48C overnight with monoclonal antibodies anti-HIS (Qiagen) and anti-c myc (Invitrogen), respectively. After three washing steps with PBS containing 0.1% Nonidet NP40, the secondary antibodies, Alexa488 and Alexa568 (Invitrogen) in 0.2% fish skin gelatine, were added for 1 h. Cells were washed three times with PBS/0.1% NP40 again and finally fixed with Moviol. Cells were observed using confocal laser microscopy (Axiovert 40 CFL, Zeiss, Gö ttingen, Germany). . Fluorescence lifetime images were acquired at 218C in a time-domain mode using two-photon excitation at 850 nm by a picosecond Mai Tai laser (Spectra-Physics-Newport, Irvine, CA, USA) pulsing at 80 MHz rate. A Leica HCS APO L63/0.9 U-V-I lens was used to acquire 256 × 256 pixel images at the zoom 4 setting with 64 time bins during 3 min periods. Confocal images were acquired on the same microscope in the two-photon mode, except that the image resolution was increased to 512 × 512 pixels. 29 Fluorescence decay in each pixel of an image was fitted with a single-exponential function using the SPCImage software (Becker & Hickl) to obtain a fluorescence lifetime image. The ImageJ software (National Institutes of Health) was used to extract the fitted lifetime values from the A-band regions. First, a threshold was applied to an intensity image, and a selection mask was created that included all A-bands in the image. The mask was applied to a fluorescence lifetime image, and a profile of lifetime values distribution in the mask with 5 ps bins was generated.
Statistics
Statistical difference between mean values was calculated using Student's t-test for unpaired or paired values and were considered significant at P-values of ,0.05.
Results
3.1 Surface plasmon resonance spectroscopy showed that mutated hVLC-1s bind weaker to the myosin lever arm than normal hVLC-1
To study the functional binding differences between normal and mutated hVLC-1 forms to myosin, we used rb-MYH 664 -915 IQ2 ala4 . 24, 25 Affinity of the M149V, E143K, A57G, and R154H mutated hVLC-1/ rb-MYH 664 -915 IQ2 ala4 complexes was significantly (P , 0.05 to P , 0.01) two-to three-fold lower compared with the normal hVLC-1/rb-MYH 664 -915 IQ2 ala4 complex interaction (K D ¼ 41 nM) ( Figure 1A -C, Table 1 ).
In particular, hVLC-1 E56G showed an 30-fold reduced affinity (K D ¼ 1310 nM) with the IQ1 domain of the myosin lever compared with the hVLC-1 (41 nM). The lower affinity of hVLC-1 E56G to the myosin lever arm was mainly due to a significantly higher k off , which was 10-fold faster (P , 0.001) compared with normal hVLC-1/ rb-MYH 664 -915 IQ2 ala4 complex ( Figure 1C , Table 1 ).
Since hVLC-1 E56G showed the strongest effects on myosin binding, we investigated the E56G mutation in more detail.
CD spectra of recombinant hVLC-1 and hVLC-1 E56G forms
CD spectra were measured to study the secondary structures of recombinant hVLC-1 and hVLC-1E56G forms ( Figure 1D ). Both hVLC-1 isoforms revealed CD spectra having negative bands at 222 and 208 nm and a positive band at 193 nm, which is typical of mainly a-helical proteins. hVLC-1 and hVLC-1 E56G showed similar degrees of a-helicity, which were estimated to amount to 50%. The high proportions of a-helical secondary structure are in accordance with the known EF-hand structure of MLCs. 3 -6 The thermal stability of hVLC-1 was not compromised by the E56G mutation ( Figure 1E ).
Intracompartmental sorting of exogenous hVLC-1 and hVLC-1 E56G in cardiomyocytes
Cultured primary neonatal rat cardiomyocytes were co-transfected with equal amounts of HIS-hVLC-1 and myc-hVLC-1 E56G cDNA.
Transfection efficiency was always 1%. Incorporation into sarcomeres was detected using immunofluorescence microscopy, with antibodies detecting the HIS or the myc tag. The intracompartmental sorting patterns of hVLC-1 and hVLC-1 E56G were clearly different.
The correct localization of HIS-hVLC-1 could be detected in many sarcomeres, whereas myc-hVLC-1 E56G remained predominantly cytoplasmic ( Figure 2A) . A total amount of 264 cardiomyocytes were analysed. Ninety-five per cent of the cardiomyocytes revealed sarcomeres with preferential hVLC-1 incorporation, whereas 5% revealed sarcomeres with hVLC-1 E56G 36 h after co-transfectionalmost all cardiomyocytes revealed both normal and mutated hVLC-1 in their sarcomeres (not shown). Hence, hVLC-1 E56G still integrates into sarcomeres, but its sarcomeric incorporation is retarded in the presence of normal hVLC. Neonatal cardiomyocytes single-transfected with myc-hVLC-1
E56G
or HIS-hVLC-1 cDNA incorporated hVLC-1 or hVLC-1 E56G into their sarcomeres, demonstrating the capacity for sarcomere incorporation hVLC-1 E56G in the absence of hVLC-1 ( Figure 2B ).
Fluorescence lifetime imaging of hVLC-1 and hVLC-1 E56G in permeabilized muscle fibres
To estimate the efficiency of ELC exchange in muscle fibres, muscle fibre protein composition was analysed using 8% SDS-PAGE. ELC replacement was estimated comparing the coumarin fluorescence of isolated recombinant hVLC-1 as standard with the coumarinfluorescence obtained with muscle fibres replaced with hVLC-1 or hVLC-1 E56G . Based on these calculations, 58 + 7% (3 fibres) and 76 + 11 (3 fibres) of the endogenous ELC was replaced with hVLC-1 and hVLC-1 E56G , respectively ( Figure 3A) .
To assess structural differences between coumarin-labelled hVLC-1 and hVLC-1 E56G , their fluorescence lifetimes were measured in relaxing solution, using FLIM. Those measurements were independent of the concentration or the extent of exchange into fibres. The fluorescence decays in each pixel of an image were fitted with a singleexponential function, and a Gaussian distribution of fluorescence lifetime was found in the A-bands ( Figure 3B) . Analysis of the mean fluorescence lifetimes showed that hVLC-1 had a significantly (P , 0.05) shorter lifetime than hVLC-1 E56G (1728 + 19 vs. 1768 + 10 ps in psoas muscle and 1662 + 17 vs. 1698 + 12 ps in soleus muscle; n ¼ 3 fibres each) ( Figure 3C ).
Discussion
In this study, we investigated structural and functional features of normal and M149V, E143K, A57G, E56G, and R154H mutated hVLC-1 forms. For protein-binding studies, we used the myosin head-rod fragment with an alanine-mutated IQ2 domain, i.e. rb-MYH 664 -915 IQ2 ala4 which remains monomeric in solution, reveals a stretched conformation, and shows strong interactions with ELC isoforms, as demonstrated recently. 25 In fact, the hVLC-1/rb-MYH 664 -915 IQ2 ala4 complex revealed a K D in the nanomolar range (42 nM) which is in close agreement with a recently obtained value. 24 Using surface plasmon resonance, we observed significantly (twoto three-fold) reduced MYH affinity to M149V, E143K, A57G, or R154H mutated hVLC-1 compared with normal hVLC-1. In particular, E56G-mutated hVLC-1 (hVLC-1 E56G ) revealed an 30-fold higher K D than the hVLC-1/MYH 664 -915 IQ2 ala4 complex due to a significantly higher k off . Amino acid E56, which is located in the a-helix of the first EF hand, seems to be critical for the ELC function, as it is highly conserved among many species. Because of its strong functional effect, we investigated the E56G mutation of hVLC-1 in more detail. This mutation was identified in a clinical study which analysed 197 unrelated cases of familial or sporadic HCM in France. 14 The authors detected 97 mutations in six different genes coding for sarcomeric proteins, the majority of cases (82%) in the myosin-binding protein C and b-MyHC genes. The E56G mutation in the MYL3 gene was found in one patient with familial HCM, which accounted for ,1% of all analysed cases. At the moment, no additional clinical information is available for the patient with the MYL3 mutation. The E56G mutation does not seem to induce a change of the secondary structure strong enough to be detectable by CD. Both recombinant hVLC-1 and hVLC-1 E56G revealed comparable high degrees of a-helicity in their CD spectra, which is typical of the EF-hand structure of calmodulin or the MLC. 3 -6 In addition, the E56G mutation did not compromise the stability of the hVLC-1 as detected by CD-based thermal stability analysis ( Figure 1E ). Nevertheless, we Effects of mutations of essential myosin light chains co-expression of hVLC-1 E56G with hVLC-1 in neonatal cardiomyocytes. We could indeed show in this study that incorporation of lowaffinity hVLC-1 E56G into the sarcomeres of neonatal cardiomyocytes was substantially suppressed when competing with normal hVLC-1. This is in line with our recent work showing improved sarcomeric sorting specificity of the high-affinity hALC-1 isoform compared with hVLC-1. 24 It seems to be interesting to note that also different skeletal muscle ELC isoforms revealed specific sarcomeric sorting activities, 31 although their myosin affinities are not yet determined.
Elastic properties of the lever arm determine force generation of myosin molecules. Increasing the rigidity of the lever arm, therefore would power up force generation. 32 Taking up this concept, the weak sarcomeric integration and myosin affinity of mutated hVLC-1 could (i) prevent the formation of high-force-generating ELC/MYH complexes, and (ii) decrease the spring constant of the lever arm and thus, force generation of the individual myosin cross-bridge. We are currently testing this hypothesis by generating transgenic mice overexpressing normal or E56G-mutated hVLC-1. In summary, we showed that, in particular, the E56G mutation of hVLC-1 revealed a substantially weaker binding complex with the myosin lever arm and disturbed conformation if bound to myosin in permeabilized muscle fibres. This loss-of-function mutation could explain the observed failing sarcomeric integration of hVLC-1 E56G in mammalian cardiomyocytes and may provide a new pathomechanism to explain the development of HCM by cardiac ELC mutations.
